Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | HMPL-306 |
| Trade Name | |
| Synonyms | HMPL 306|HMPL306 |
| Drug Descriptions |
HMPL-306 specifically inhibits mutant IDH1/2, resulting in decreased conversion of alpha-ketoglutarate into 2-hydroxyglutarate, and potentially leading to inhibition of of IDH1/2 mutant tumor cell proliferation (NCI Drug Dictionary, J Clin Oncol 2025 43: 16_suppl, 2013). |
| DrugClasses | IDH Inhibitor (Pan) 3 |
| CAS Registry Number | NA |
| NCIT ID | C175602 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| HMPL-306 | HMPL-306 | 5 | 2 |